What is the treatment for vaginitis yeast infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Vulvovaginal Candidiasis (Yeast Infection)

For uncomplicated vulvovaginal candidiasis (VVC), both topical azole preparations and oral fluconazole 150 mg as a single dose are highly effective first-line treatments with cure rates of 80-90%. 1

Classification of Vulvovaginal Candidiasis

VVC can be classified into two categories which guide treatment approach:

  1. Uncomplicated VVC (90% of cases):

    • Mild-to-moderate symptoms
    • Sporadic, infrequent episodes
    • Likely caused by C. albicans
    • In immunocompetent patients
  2. Complicated VVC (10% of cases):

    • Severe symptoms
    • Recurrent episodes (≥4 episodes/year)
    • Non-albicans Candida species
    • Abnormal host factors (diabetes, immunosuppression, pregnancy)

Treatment Options for Uncomplicated VVC

Topical Intravaginal Agents:

  • Clotrimazole:

    • 1% cream 5g intravaginally for 7-14 days 1, 2
    • 100mg vaginal tablet for 7 days 1
    • 100mg vaginal tablet, two tablets for 3 days 1
    • 500mg vaginal tablet, single application 1
  • Miconazole:

    • 2% cream 5g intravaginally for 7 days 1, 3
    • 200mg vaginal suppository, one suppository for 3 days 1
    • 100mg vaginal suppository, one suppository for 7 days 1
    • 1200mg vaginal insert, single dose 3
  • Other topical options:

    • Butoconazole 2% cream 5g intravaginally for 3 days 1
    • Tioconazole 6.5% ointment 5g intravaginally in a single application 1
    • Terconazole 0.4% cream 5g intravaginally for 7 days 1
    • Terconazole 0.8% cream 5g intravaginally for 3 days 1
    • Terconazole 80mg vaginal suppository, one suppository for 3 days 1
    • Nystatin 100,000-unit vaginal tablet, one tablet for 14 days 1

Oral Agent:

  • Fluconazole 150mg oral tablet, single dose 1, 4, 5

Treatment for Complicated VVC

Severe VVC:

  • Fluconazole 150mg, two sequential doses given 3 days apart 6
  • OR extended duration of topical therapy (7-14 days)

Recurrent VVC:

  1. Induction phase:

    • Fluconazole 150mg every 72 hours for 3 doses (days 1,4, and 7) 1
    • OR 14 days of topical therapy
  2. Maintenance phase:

    • Fluconazole 150mg weekly for 6 months 1
    • OR ketoconazole 100mg daily 1
    • OR itraconazole 100mg every other day 1
    • OR daily therapy with any topical azole 1

Non-albicans Candida:

  • Boric acid 600mg in gelatin capsule intravaginally daily for 14 days 1
  • OR topical flucytosine 1

Treatment Efficacy

  • Single-dose oral fluconazole (150mg) is as effective as 7-day regimens of intravaginal clotrimazole, with clinical cure rates of 94% and 97% respectively at 14 days post-treatment 5
  • For severe VVC, a two-dose regimen of fluconazole (150mg given 3 days apart) achieves significantly higher clinical cure rates compared to a single dose 6
  • Patient preference often favors oral therapy, with 73% of patients preferring oral treatment over intravaginal options 7

Important Considerations

  • Self-medication with OTC preparations should only be advised for women previously diagnosed with VVC who have a recurrence of the same symptoms 1
  • Women whose symptoms persist after using an OTC preparation or who have a recurrence within 2 months should seek medical care 1
  • Non-albicans Candida infections respond poorly to azole therapy and may require alternative treatments 6
  • Identifying Candida by culture in the absence of symptoms should not lead to treatment, as 10-20% of women normally harbor Candida species in the vagina 1

Follow-up

  • Patients should see improvement within 2-3 days of starting treatment
  • If symptoms persist after completing therapy, reevaluation is necessary to confirm diagnosis and rule out other causes of vaginal symptoms

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.